Thus, we observed an elevated expression of ADGRG1 specifically in T cells of AML, particularly in tumor-reactive T cells, suggesting its potential utility as a marker for tumor-reactive T cells. The gene discussed is ADGRG1; the disease is acute myeloid leukemia.